CONGRESS ASSET MANAGEMENT CO /MA - HORIZON THERAPEUTICS PUB L ownership

HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
CONGRESS ASSET MANAGEMENT CO /MA ownership history of HORIZON THERAPEUTICS PUB L
ValueSharesWeighting
Q3 2023$1,203,176
+0.5%
10,400
-10.7%
0.01%
+10.0%
Q2 2023$1,197,688
-81.5%
11,645
-80.4%
0.01%
-83.3%
Q1 2023$6,485,426
-95.7%
59,423
-95.5%
0.06%
-96.0%
Q4 2022$149,434,710
+54.3%
1,313,135
-16.1%
1.50%
+44.3%
Q3 2022$96,842,000
-23.4%
1,564,746
-1.2%
1.04%
-14.2%
Q2 2022$126,375,000
-25.1%
1,584,445
-1.2%
1.21%
-15.7%
Q1 2022$168,742,000
-3.1%
1,603,861
-0.7%
1.44%
+8.2%
Q4 2021$174,093,000
-4.4%
1,615,559
-2.8%
1.33%
-6.7%
Q3 2021$182,067,000
+13.4%
1,662,106
-3.0%
1.42%
+5.9%
Q2 2021$160,484,000
-0.8%
1,713,835
-2.5%
1.34%
-8.1%
Q1 2021$161,807,000
+19.3%
1,758,012
-5.1%
1.46%
+14.4%
Q4 2020$135,580,000
-7.1%
1,853,457
-1.4%
1.28%
-19.2%
Q3 2020$146,017,000
+34.4%
1,879,730
-3.9%
1.58%
+22.4%
Q2 2020$108,680,000
+1444.4%
1,955,384
+723.0%
1.29%
+1107.5%
Q1 2020$7,037,000
-23.7%
237,581
-6.7%
0.11%
-4.5%
Q4 2019$9,217,000
+27.5%
254,624
-4.1%
0.11%
+20.4%
Q3 2019$7,231,000
+7.8%
265,558
-4.8%
0.09%
+9.4%
Q2 2019$6,709,000278,8460.08%
Other shareholders
HORIZON THERAPEUTICS PUB L shareholders Q2 2021
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 1,398,990$161,84963.55%
GWM Asset Management Ltd 323,528$37,296,28831.95%
Chicago Capital Management, LLC 81,114$11,492,64530.30%
Beryl Capital Management LLC 2,040,528$236,068,68426.33%
Twin Securities, Inc. 800,784$92,643,00022.54%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 7,664,245$886,676,50422.34%
Paulson & Co. 2,103,046$243,301,39221.77%
PSquared Asset Management AG 2,001,749$231,582,34221.18%
Ergoteles LLC 121,905$14,103,18920.67%
Samson Rock Capital LLP 500,000$57,845,00018.71%
View complete list of HORIZON THERAPEUTICS PUB L shareholders